Abstract.-CsH/He mice were exposed to total-body X-irradiation of 1000 roentgens and received thereafter 107 xenogeneic Wistar rat marrow cells intravenously. In these rat-to-mouse chimeras, serum interferon-producing capacity upon injection of Newcastle disease virus was examined four weeks after grafting. Normal levels of circulating interferon were produced. The interferon, however, had the species specificity of rat interferon, being 20 times more active in rat embryo fibroblasts than in mouse embryo fibroblasts. Moreover, it behaved like rat interferon when filtered on Sephadex G-100 dextran gel, displaying one peak of activity in the 90,000 molecular-weight range and two incompletely separated peaks of 32,000 and 24,000, respectively, in the 30,000 molecularweight region. The fact that the interferon is of the donor type in rat-to-mouse chimeras permits us to conclude that circulating interferon induced by Newcastle disease virus is made in bone-marrow-derived cells.
The production of serum interferon1' 2 in CsH/He mice upon stimulation with either Sindbis or Newcastle disease virus (NDV) is almost completely inhibited within 48 hours after whole-body X-irradiation of 1000 roentgens.3 This impairment of circulating interferon response persists during the period of survival, which, in our mouse colony, is nine days after irradiation. In similarly irradiated C3H/He mice treated with syngeneic bone-marrow cells, restoration of hemopoietic function is accompanied by a reappearance of circulating interferonproducing capacity in response to viral injection. Moreover, using a minimal and an optimal amount of bone-marrow cells for grafting, we could establish a correlation between recovery of hemopoietic function and degree of regeneration of circulating interferon-producing capacity.4 This suggested that the circulating interferon-producing system was derived from bone-marrow cells. To verify this hypothesis, rat-to-mouse radiation chimeras were made by restoring Xirradiated C3H/He mice with xenogeneic Wistar rat marrow cells. The reasoning behind this experiment was as follows: circulating interferon, made by cells originating in bone marrow, should be of the donor type in xenogeneic radiation chimeras, and hence be easily detectable, because of the well-documented species specificity of interferon.5' 6 As we reported earlier, circulating interferon induced by Newcastle disease virus in rat-to-mouse radiation chimeras does indeed have the species-specific characteristics of rat interferon.4 Analysis on dextran gel (Sephadex G-100) has now provided further evidence for the donor origin of serum interferon in rat-to-mouse chimeras, as will be shown by the experiments presented in this paper.
Materials and Methods.-(1) Animals: The mice belonged to the inbred C3H/He strain, maintained by the Laboratory Animals Centre (M. R. C., Carshalton, Surrey, U. K.). We purchased breeding stock and used male progeny from first and second generations; all animals were kept under specific pathogen-free conditions and were 10 to 12 weeks old at the time of interferon induction. The rats were from the Wistar strain of the Centraal Proefdierenbedrijf, T. N. O., Zeist, Nederlands. We purchased a gravid female and used 7-week-old littermates, of both sexes, for interferon production. Radiation chimeras: (a) Mouse-to-mouse chimeras: Male C3H/He mice, aged 6 to 8 weeks, received 1000 r whole-body X-irradiation. On the same day, the animals were injected intravenously with 107 syngeneic bone-marrow cells, prepared as described previously.4 The circulating interferon response was examined 4 weeks after grafting, when the animals had normal circulating leucocyte levels but proportionally less lymphocytes than control animals. (b) Rat-to-mouse chimeras: Male C3H/He mice, aged 6 to 8 weeks, received 1000 r whole-body X-irradiation. Thereafter, they were injected intravenously with 107 Wistar rat marrow cells, the single donor for all mice being a 6-week-old male Wistar rat. The interferon-producing capacity was examined 4 weeks later. At this time, the chimeras were apparently in excellent condition.
(2) Irradiations were performed with a 225-kv X-ray machine (11 ma, filtration 0.5 mm Cu, half-value layer 1.5 mm Cu). The irradiated mice received a single whole-body dose of 1000 r. Dose rate was 35 r per minute.
(3) Newcastle disease virus, Kumarov strain, was used as the interferon inducer. In mice 0.2 ml and in rats 0.4 ml of the virus stock suspension (titer 108 Egg ID50/0.1 ml) was injected by way of an orbital sinus. Blood was drawn 6 hr later; sera were pooled according to animal groups and kept at -20'C.
(4) Gel filtration of serum was performed on dextran gel (Sephadex G-100, Pharmacia, Uppsala, Sweden) at 4VC under sterile conditions. The column was calibrated according to the method of Andrews.8 1.8 ml of serum was applied to the top of the gel, together with 0.4 ml of a 0.2% solution of Blue dextran. The effluent consisted of nine parts of NaCl 0.9% for one part 0.1 M Na phosphate buffer, pH 7.0. The effluent was collected in 6-ml fractions; the tubes were covered with a cap and kept at 4°C until interferon titrations were made.
(5) Interferon titrations were carried out by a plaque-reduction method3' 1' under a starch overlay10 using vesicular stomatitis virus as the challenge virus. Starting from the tube containing Blue dextran, all effluent fractions from dextran gel were titrated for interferon activity, both in a continuous line of mouse L cells and in a continuous line of rat WIRA cells recently derived from Wistar rat embryo fibroblasts in our laboratory. For titrations in whole serum, interferon activity was examined in L and in WIRA cells, and also in secondary mouse embryo fibroblasts.
(6) Characterization of the interferon: The viral inhibitory activity measured in the sera of mice, rats, and radiochimeras was attributed to interferon(s) for the following reasons: the inhibitory activity was nondialyzable and was destroyed by trypsin; there was no inhibitory activity against vesicular stomatitis virus in primary chick embryo fibroblasts, in a continuous line of rabbit cells (RK 13), and in a line of nonhuman primate cells (MA 104). Pools of effluent fractions from dextran gel were also tested for interferon in chicken and MA 104 cells, and no viral inhibitory activity was found.
Results.-Sera were pooled according to animal groups; the number of animals per pool is given in Table 1 . A sample from each pool was examined for interferon activity in two kinds of mouse cells, L and mouse embryo fibroblasts, and in rat WIRA cells. The ratios of interferon activity in mouse cells as compared to interferon activity in rat cells, and their reciprocal values, are given. It is evident that rat-to-mouse chimera interferon behaves like rat interferon, being 20 times more active in WIRA cells than in mouse embryo fibroblasts, and 38 times more active in WIRA cells than in L cells. In other words, circulating interferon induced by Newcastle disease virus in rat-to-mouse chimeras has the species specificity of donor rat interferon, which confirms earlier results.4 Two other points arising from Table 1 should be emphasized: first, when compared to L cells for their sensitivity to mouse interferon, mouse embryo fibroblasts are about four times more susceptible to the viral inhibitor; second, WIRA rat cells are more sensitive to mouse interferon than mouse embryo fibroblasts are to rat interferon. We shall come back to these observations in the discussion.
To characterize further circulating interferon from rat-to-mouse chimeras and to compare it to mouse and to rat interferons, respectively, a sample of each pool of sera was filtered through a Sephadex G-100 dextran gel. Interferon titrations were carried out in mouse L cells and in rat WIRA cells for each of the effluent fractions. The results are graphically represented in Figure 1 for titrations in L cells and in Figure 2 for titrations in WIRA cells.
The results obtained in both assay systems will now be analyzed for each group of animals: (a) CsH/He mouse interferon: Analysis of interferon titrations in L cells reveals a broad zone of activity, with two main peaks, one corresponding to a molecular weight of 67,000 and another to a molecular weight of 34,000. When titrated in rat cells, CsH/He mouse serum interferon presents a comparable profile of elution; the heavier peak, however, is somewhat more active than the lighter one in WIRA cells. The relatively high sensitivity of WIRA rat cells to mouse serum interferon, as noticed in titrations of whole serum, is still evident with filtered interferon.
(b) Mouse-to-mouse serum interferon: These chimeras were made to ascertain that lethal irradiation, followed by a graft of syngeneic bone-marrow cells, did not alter per se the profile of elution of serum interferon. This was important for the subsequent interpretation of results obtained with rat-to-mouse chimeras. The elution pattern of interferon activity in L cells and in WIRA cells is similar for mouse and mouse-to-mouse chimeras, except that the heavy peak is relatively more important in the chimera. The dispersion of interferon activity and the localization of the peaks, however, are identical. It can be concluded that serum interferon from syngeneic chimeras cannot be distinguished, by gel filtration on Sephadex G-100, from mouse serum interferon. in L cells. Even in effluent fractions diluted 1:3, the reduction of challenge virus plaques was too low to be converted into units by extrapolation from the interferon units reference curve. Figure 1 shows two zones, in which a plaque reduction effect was repeatedly found, although interferon activity could not be expressed in measurable units. It must be pointed out that interferon-like activity is present in two regions: one in the 90,000 molecular-weight range, where mouse serum interferon is absent, and the other one in the 30,000 molecularweight range, where the lighter peak of mouse interferon is found. When analyzed in homologous WIRA cells, effluent fractions from rat interferon filtration display a broad dispersion of interferon activity, extending from molecularweights of up to about 100,000 to down to about 15,000. There is one heavy peak corresponding to a molecular weight of about 94,000. (This value has been extrapolated by prolonging the line of the standard proteins graph; it is an approximation because it is close to the exclusion limit of Sephadex G-100.) The lighter component of rat interferon is localized in the 30,000 molecularweight region. On repeated determinations, from two runs, we constantly found two incompletely separated peaks, one corresponding to a molecular weight of 30,000-34,000 and the other to a molecular weight of 23,000-26,000.
(d) Rat-to-mouse serum interferon: When titrated either in rat WIRA cells or in mouse L cells, the profile of elution of rat-to-mouse chimera interferon is comparable to the profile of elution of control rat interferon. In WIRA cells, one finds the two regions of interferon activity described for rat interferon: a high-molecular-weight peak, localized in the 90,000 region, and a region with two lighter peaks of -432,000 and 4±24,000, respectively. In mouse L cells, there is hardly any measurable interferon activity. In repeated determinations, one always finds two zones where plaque reduction is constantly observed: one is situated in the 90,000 molecular-weight region and the other in the 30,000 region. As was the case for rat serum interferon, this plaque-reduction phenomenon is obtained only with a low dilution (1/s to '/lo) of effluent fractions and, even under these conditions, the plaque reduction is less than 25 per cent, which makes precise calculation of interferon activity in units impossible.
Discussion.-In this study, rat-to-mouse chimeras were obtained by grafting rat marrow cells into lethally irradiated mice. This type of restoration has been reported by several investigators with varying results, the animals succumbing a few weeks to several months after transplantation.'2-'4 In our hands, the administration of Wistar rat cells to irradiated C3H/He mice proved successful, since those animals that were not used for experimentation survived at least three months. The fact that our animals are kept under specific pathogen-free conditions probably contributed to the successful establishment of the graft. As amply documented, rat-to-mouse chimera leucocytes are of the rat type and make rat proteins."5-8 Therefore, it was reasoned that if interferon were made in cells originating in bone marrow, it should have the characteristics of donor rat interferon. If, on the contrary, circulating interferon induced by Sindbis and Newcastle disease virus did not come from the regenerated hemopoietic system, it should have the characteristics of recipient mouse interferon. In a previous article, we reported that, in rat-to-mouse chimeras, interferon had the species specificity of rat interferon, which indicated that upon injection of Sindbis or Newcastle disease virus, circulating interferon was made in cells derived from bone marrow.4 These experiments have now been repeated with Newcastle disease virus as inducer, and interferon was analyzed not only for its species specificity, but also for its filtration characteristics on dextran gel (Sephadex G-100). Rat-to-mouse chimera interferon was compared to mouse and rat interferon, and also to mouse-to-mouse chimera interferon.
Concerning the species specificity of interferon, several remarks can be made.
First, rat and rat-to-mouse whole-serum interferons have a much lower activity either in mouse embryo fibroblasts and in L cells than in rat WIRA cells, an observation that confers rat species specificity to rat-to-mouse chimera interferon.
By contrast, although mouse and mouse-to-mouse serum interferons have a definitely higher activity in mouse cells than in rat cells, the sensitivity of rat WIRA cells to mouse interferon remains fairly high. A certain degree of cross-reactivity of interferon in related species has been reported by Buckler and Baron, who observed that mouse serum interferon retained 5 per cent of its homologous antiviral activity in rat and hamster embryo fibroblasts.'9 This is within the range of our results with rat and rat-to-mouse chimera interferon, which exert only 5 to 7 per cent of their activity in mouse embryo fibroblasts (Table 1) . Mouse serum interferon, however, exerts 16 per cent of its activity in WIRA cells, which implies that the latter are comparatively two to three times more sensitive to mouse interferon than are mouse embryo fibroblasts to rat interferon. We have no ready explanation for this phenomenon. When the four experimental groups of sera were tested for interferon in more distant species, such as chicken, rabbit, or primate cells, no viral inhibitory activity at all was found. As for the relative sensitivity of different mouse cells to homologous mouse interferon, we constantly find that mouse embryo fibroblasts are four times more sensitive than L cells. To express the ratio of activity of mouse interferon in rat cells, and vice versa, we feel that it is more appropriate to use the ratio of activity in mouse embryo fibroblasts to activity in WIRA than the ratio of activity in L to activity in WIRA; WIRA cells, indeed, are recently derived from rat embryo fibroblasts.
The analysis of interferon activity in effluent fractions from Sephadex G-100 in mouse L cells and in rat WIRA cells deserves several comments. The two main peaks of interferon observed for mouse serum, both in L and in WIRA cells, correspond to molecular weights of 67,000 and 34,000. These values are within the range of those recently reported by Hallum et al.20 for serum interferon in one strain of Balb/c and two strains of Swiss mice 6 to 18 hours after an intravenous injection of Newcastle disease virus. We found both peaks on repeated filtrations. No interferon activity could be found at either end of the run, viz., up to tube 31 (mol wt 77,000) and from tube 51 (mol wt 20,000). Between the peaks, however, interferon activity, although at low levels, was present in all tubes, which points to a dispersion of mouse serum interferon activity after filtration on Sephadex G-100. This dispersion is still more evident when titrations are carried out in cells more sensitive to interferon, such as mouse embryo fibroblasts (unpublished observation), or even in L cells, when the interferon titer of the applied serum is high, as is the case with C57BL mouse interferon.
With regard to filtration on Sephadex G-100, interferon from mouse-to-mouse radiation chimeras is comparable to mouse interferon. Two peaks of interferon activity, at 67,000 and 34,000, respectively, are present, together with the dispersion of interfering activity from tube 31 to 50. This indicates that a 1000-r X-irradiation with subsequent syngeneic bone-marrow grafting does not modify, per se, the interferon response to Newcastle disease virus six weeks later.
After dextran gel filtration, rat serum interferon is hardly detectable in L cells. This was expected, considering the low interferon activity observed when whole serum was tested in these cells. The two areas designated by a bar in Figure 1 correspond to zones where plaque reduction was constantly found, although, at such a low level of activity, precise determinations of interferon in units could not be given. It is relevant to point out, however, that the high-molecularweight component of rat serum interferon is found in a region where mouse interferon activity is absent. This is confirmed by titrations of effluent fractions in homologous WIRA cells, where the high-molecular-weight peak can be estimated as ±94,000. Analysis of the complete profile of elution of rat interferon in rat cells reveals a dispersion with a broad zone of activity around 30,000. There are possibly two separate peaks in this region, one corresponding to a molecular weight of i 32,000 and the other to a molecular weight of ± 24,000. Interferon components of proximate molecular weights, 51,000 and 45,000, respectively, have been described for circulating rabbit interferon induced by Newcastle disease virus. 22 We feel, however, that more work is needed before the existence of two different components in the 30,000 region will be firmly established for rat interferon. Dispersion of rat interferon activity from 25,000 to 100,000 was previously reported by Schonne, following Sephadex G-100 filtration of interferon induced by Sindbis virus in a continuous line of rat mammary tumor cells. 23 No results for rat serum interferon are available for comparison.
Analysis on L cells of rat-to-mouse chimera interferon activity, in effluent fractions from dextran gel, reveals two zones where plaque reduction, although constantly found, remains too low to permit precise determinations. The salient feature, however, is the presence of interferon activity in the 90,000 molecularweight range, where rat interferon is found and where mouse and mouse-to-mouse chimera interferon show no activity. Titrations of effluent fractions from ratto-mouse interferon in WIRA cells reveal a dispersion similar to that observed for rat interferon, with one heavy peak at 94,000, and a zone with two lighter peaks around 30,000; this profile of elution is quite superposable to that observed for rat interferon. The question of a mouse interferon component in serum from heterologous chimeras can be raised. It can be envisaged, indeed, that in the 30,000 molecular-weight zone, part of the total interferon is of mouse origin and cannot be distinguished from rat interferon when titrated in WIRA cells. However, the very low activity of rat-to-mouse interferon in L cells indicates that, even if a mouse component were present in this fraction, it would represent only a very minor part of total serum interferon.
It can therefore be concluded that circulating interferon induced by Newcastle disease virus in rat-to-mouse chimeras has the species specificity of rat interferon and behaves like rat interferon when filtered on Sephadex G-100. This means
